Dornan David 4
4 · Bolt Biotherapeutics, Inc. · Filed Feb 8, 2021
Insider Transaction Report
Form 4
Dornan David
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-04+110,000→ 110,000 totalExercise: $20.00Exp: 2031-02-03→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/48th of the Shares will vest upon the Reporting Person completing each month of continuous service following February 4, 2021.